Prarthana Gowda

Prarthana Gowda

Auto-generated profile, based on publicly available information

Prarthana Gowda

Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2022 in Biomedical Materials & Devices
Verified
Journal Article
Open access
PDF file
JPJeremy M. Perrelle
Jeremy M. Perrelle
ABAndrew James Boreland
Andrew James Boreland
JGJasmine M. Gamboa
Jasmine M. Gamboa
PGPrarthana Gowda
Prarthana Gowda
SMSanjeeva Murthy
Sanjeeva Murthy
Injuries to the nervous system present formidable challenges to scientists, clinicians, and patients. While regeneration within the central nervous system is minimal, peripheral nerves can regenerate, albeit with limitations. The regenerative mechanisms of the peripheral nervous system thus provide fertile ground for clinical and scientific advancement, and opportunities to learn fundamental lessons regarding nerve behavior in the context of regeneration, particularly the relationship of axons to their support cells and the extracellular matrix environment. However, few current interventions adequately address peripheral nerve injuries. This article aims to elucidate areas in which progress might be made toward developing better interventions, particularly using synthetic nerve grafts. The article first provides a thorough review of peripheral nerve anatomy, physiology, and the regenerative mechanisms that occur in response to injury. This is followed by a discussion of currently available interventions for peripheral nerve injuries. Promising biomaterial fabrication techniques which aim to recapitulate nerve architecture, along with approaches to enhancing these biomaterial scaffolds with growth factors and cellular components, are then described. The final section elucidates specific considerations when developing nerve grafts, including utilizing induced pluripotent stem cells, Schwann cells, nerve growth factors, and multilayered structures that mimic the architectures of the natural nerve.